Skip to content
University of Colorado Anschutz Medical Campus CU Anschutz
  • Webmail
  • UCD Access
  • Canvas
  • Quick Links
 

Tools & Resources

  • Events Calendar
  • Newsroom
  • Strauss Health Sciences Library
  • Department A-Z Directory
  • Campus Directory
  • Leadership
  • Faculty & Staff Resources
  • Supporter & Alumni Resources
  • Student Resources
  • Campus Map
  • University Policies

CU Campuses

  • CU Anschutz Medical Campus
  • CU Boulder
  • CU Colorado Springs
  • CU Denver
  • CU System
  • CU Online

CU Anschutz Medical Campus

  • School of Dental Medicine
  • Graduate School
  • School of Medicine
  • College of Nursing
  • Skaggs School of Pharmacy and Pharmaceutical Sciences
  • Colorado School of Public Health

Biobank

Colorado Center for Personalized Medicine

Give Us Feedback

  • Home
  • About
    • How It Works
    • FAQs
    • Newsletter
      • Newsletter Archive
  • Enrolled Participants
    • Updating Your Biobank Consent Form
    • Participant Profile
    • Partnerships
  • Return of Results
  • Providers
    • Providers FAQs
    • Results
      • PGX
        • Brivaracetam
        • Brivaracetam Tipsheet
        • Clobazam
        • Clobazam Tipsheet
        • Clopidogrel
        • DPYD
        • DPYD Tipsheet
        • PPIS
        • PPIS Tipsheets
          • Poor Metabolizers
          • Intermediate Metabolizers
          • Rapid Metabolizers
          • Ultrarapid Metabolizers
        • SSRIS
        • SSRIS Tipsheet
        • Voriconazole
        • Voriconazole Tipsheet
        • Statins
        • Statins Tipsheet Decreased
        • Statins Tipsheet Poor
    • Resources
  • Investigators & Partners
    • Resources
    • Access to Biobank Committee (ABC)
    • Application Process
  • Withdraw Form
  • Contact Us
University Quick Links
  • Home
  • Providers
  • Results
  • PGX
  • PPIS Tipsheets

PPIs & CYP2C19

Learn More

Choose a Tip Sheet based on CYP2C19 Metabolizer Phenotype

PPIs Tip Sheets

 

The following information is intended for use by providers who are attempting to prescribe certain PPIs (omeprazole, pantoprazole, lansoprazole, and dexlansoprazole) to Biobank participants with certain CYP2C19 genetic variants. 

CYP2C19 Intermediate Metabolizers

CYP2C19 Poor Metabolizers

CYP2C19 Rapid Metabolizers

CYP2C19 Ultrarapid Metabolizers

Colorado Center for Personalized Medicine

University of Colorado Anschutz Medical Campus

CU Anschutz

Fitzsimons Building

13001 East 17th Place

Mailstop F563

Building 500, 5th Floor East

Aurora, CO 80045


Contact Us
  • (303) 724-9944
  • CCPM-Biobank@ucdenver.edu
Study Title
  • Colorado Center for Personalized Medicine (CCPM) Biobank Research Study
COMIRB#
  • 15-0461 PI: Dr. David Kao: Medical Director, CCPM
  • Contact Us
  • Website Feedback
  • CU System
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Accreditation
  • Employment
  • Give Now
 

© 2022 The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.

CMS Login

Webmail

UCD Access

Canvas

Opens in a new window Opens document in a new window